SG Americas Securities LLC Buys Shares of 11,861 908 Devices Inc. (NASDAQ:MASS)

SG Americas Securities LLC purchased a new position in shares of 908 Devices Inc. (NASDAQ:MASS) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 11,861 shares of the company’s stock, valued at approximately $133,000.

Several other institutional investors and hedge funds have also made changes to their positions in MASS. ARK Investment Management LLC raised its position in 908 Devices by 1.0% during the third quarter. ARK Investment Management LLC now owns 4,013,460 shares of the company’s stock worth $26,730,000 after acquiring an additional 40,555 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of 908 Devices by 50.3% during the 1st quarter. Ameriprise Financial Inc. now owns 1,876,467 shares of the company’s stock worth $16,138,000 after purchasing an additional 627,742 shares during the last quarter. BlackRock Inc. lifted its stake in 908 Devices by 2.2% in the 2nd quarter. BlackRock Inc. now owns 1,730,883 shares of the company’s stock valued at $11,874,000 after buying an additional 37,813 shares in the last quarter. Vanguard Group Inc. grew its holdings in 908 Devices by 25.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,422,151 shares of the company’s stock valued at $23,394,000 after buying an additional 288,923 shares during the last quarter. Finally, State Street Corp grew its holdings in 908 Devices by 1.0% during the 1st quarter. State Street Corp now owns 802,162 shares of the company’s stock valued at $6,899,000 after buying an additional 7,553 shares during the last quarter. 88.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at 908 Devices

In other 908 Devices news, CEO Kevin J. Knopp sold 9,071 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $7.00, for a total value of $63,497.00. Following the completion of the transaction, the chief executive officer now directly owns 411,981 shares in the company, valued at approximately $2,883,867. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other 908 Devices news, CEO Kevin J. Knopp sold 9,071 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $7.00, for a total value of $63,497.00. Following the sale, the chief executive officer now directly owns 411,981 shares of the company’s stock, valued at approximately $2,883,867. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Joseph H. Iv Griffith sold 5,698 shares of 908 Devices stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $7.00, for a total value of $39,886.00. Following the completion of the sale, the chief financial officer now owns 89,711 shares of the company’s stock, valued at approximately $627,977. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,001 shares of company stock valued at $139,955. Company insiders own 27.80% of the company’s stock.

908 Devices Stock Down 3.5 %

NASDAQ MASS opened at $5.59 on Thursday. 908 Devices Inc. has a fifty-two week low of $4.85 and a fifty-two week high of $12.51. The business has a fifty day moving average of $6.89 and a 200-day moving average of $7.10. The stock has a market cap of $183.97 million, a price-to-earnings ratio of -4.95 and a beta of 0.93.

908 Devices (NASDAQ:MASS) last announced its earnings results on Tuesday, March 5th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.03. 908 Devices had a negative net margin of 72.47% and a negative return on equity of 21.09%. The firm had revenue of $14.40 million during the quarter, compared to the consensus estimate of $14.16 million. During the same quarter in the previous year, the company posted ($0.31) EPS. The firm’s revenue for the quarter was up 24.1% on a year-over-year basis. As a group, analysts anticipate that 908 Devices Inc. will post -1.29 EPS for the current year.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.